The cytoplasmic domain of TGFβR3 through its interaction with the scaffolding protein, GIPC, directs epicardial cell behavior  by Sánchez, Nora S. et al.
Developmental Biology 358 (2011) 331–343
Contents lists available at SciVerse ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyThe cytoplasmic domain of TGFβR3 through its interaction with the scaffolding
protein, GIPC, directs epicardial cell behavior
Nora S. Sánchez a, Cynthia R. Hill a, Joseph D. Love a, Jonathan H. Soslow b, Evisabel Craig c,d,
Anita F. Austin a,e, Christopher B. Brown b, Andras Czirok f,g, Todd D. Camenisch c,d, Joey V. Barnett a,⁎
a Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
b Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
c Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ 85721, USA
d Steele Children's Research Center and Bio5 Institute, University of Arizona, Tucson, AZ 85721, USA
e Department of Cardiovascular Biology, Meharry Medical College, Nashville, TN 37208, USA
f Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA
g Department of Biological Physics, Eotvos University, Budapest, HungaryAbbreviations: FGF, Fibroblast Growth Factor; FG
Receptor; GFP, Green Fluorescent Protein; GIPC, GTP
subunits interacting protein C-terminus; HMW-HA, High
Acid; IGF-IR, Insulin growth factor receptor, type I; P
Factor; PDGFR, Platelet-Derived Growth Factor Recep
22 kDa actin-binding protein; SMαA, Smooth Muscle Al
ing Growth Factor-Beta Receptor I; TGFβR2, Transformin
II; TGFβR3, Transforming Growth Factor-Beta Receptor I
Factor-Beta; TUNEL, Terminal deoxynucleotidyl transf
phosphate Nick End Labeling; VEGF, Vascular Endothelia
Tumor-1; ZO-1, Zonula Occludins-1.
⁎ Corresponding author at: Department of Pharma
Medical Center, Room 476 RRB, 2220 Pierce Avenue, N
Fax: +1 615 343 6532.
E-mail address: joey.barnett@vanderbilt.edu (J.V. Ba
0012-1606/$ – see front matter © 2011 Elsevier Inc. Al
doi:10.1016/j.ydbio.2011.08.008a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 14 May 2011
Revised 18 July 2011
Accepted 10 August 2011
Available online 25 August 2011
Keywords:
Coronary vessels
Epicardium
TGFβ
TGFβR3The epicardium is a major contributor of the cells that are required for the formation of coronary vessels. Mice
lacking both copies of the gene encoding the Type III Transforming Growth Factor β Receptor (TGFβR3) fail to
formthe coronary vasculature, but themolecularmechanismbywhich TGFβR3 signals coronary vessel formation
is unknown.Weused intact embryos and epicardial cells fromE11.5mouse embryos to reveal themechanismsby
which TGFβR3 signals and regulates epicardial cell behavior. Analysis of E13.5 embryos reveals a lower rate of
epicardial cell proliferation and decreased epicardially derived cell invasion in Tgfbr3−/− hearts. Tgfbr3−/−
epicardial cells in vitro show decreased proliferation and decreased invasion in response to TGFβ1 and TGFβ2.
Unexpectedly, loss of TGFβR3 also decreases responsiveness to two other important regulators of epicardial cell
behavior, FGF2 andHMW-HA. Restoring full length TGFβR3 in Tgfbr3−/− cells rescued deﬁcits in invasion in vitro
in response TGFβ1 and TGFβ2 as well as FGF2 and HMW-HA. Expression of TGFβR3 missing the 3 C-terminal
amino acids that are required to interact with the scaffolding protein GIPC1 did not rescue any of the deﬁcits.
Overexpression of GIPC1 alone in Tgfbr3−/− cells did not rescue invasion whereas knockdown of GIPC1 in
Tgfbr3+/+ cells decreased invasion in response to TGFβ2, FGF2, and HMW-HA. We conclude that TGFβR3
interaction with GIPC1 is critical for regulating invasion and growth factor responsiveness in epicardial cells and
that dysregulation of epicardial cell proliferation and invasion contributes to failed coronary vessel development
in Tgfbr3−/−mice.FR, Fibroblast Growth Factor
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Coronary vessel development begins when a group of mesothelial
cells known as the proepicardium are transferred to the surface of theheart where they form an epithelial sheet termed as the epicardium
(Manner, 1993; Olivey et al., 2004; Tomanek, 2005; Viragh and Challice,
1981). A subset of these cells undergoes epithelial to mesenchymal
transformation (EMT) and invades the subepicardial spacewith someof
these cells continuing into themyocardium. Cells may differentiate into
several cell lineages (Cai et al., 2008; Christoffels et al., 2009;
Gittenberger-de Groot et al., 1998; Grieskamp et al., 2011; Lie-Venema
et al., 2007, 2008) including vascular smooth muscle cells and cardiac
ﬁbroblasts (Mikawa and Fischman, 1992; Poelmann et al., 1993). The
origin of endothelial cells is controversial (Lavine et al., 2008; Tomanek
et al., 2006; Xiong, 2008), but recent work (Red-Horse et al., 2010)
demonstrates that these cells arise from the sinus venosus. Together
these cells contributed by the epicardium and sinus venosus are
coordinately regulated to form the coronary vasculature.
Deletion of the gene encoding the Type III Transforming Growth
Factor β Receptor (TGFβR3) inmice is embryonically lethal due to failed
coronary vessel development (Compton et al., 2007). TGFβR3 contains a
heavily glycosylated extracellular domain and a highly conserved, 43
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(Lopez-Casillas et al., 1991; Wang et al., 1991). TGFβR3 is required for
the high afﬁnity binding of TGFβ2 but also binds TGFβ1 and TGFβ3
(Lopez-Casillas et al., 1993). In addition, TGFβR3 can bind and signal in
response to BMP2 (Kirkbride et al., 2008) and function as an inhibin
receptor (Wiater et al., 2006). Upon binding TGFβ, TGFβR3 presents
ligand to the Type I (TGFβR1) and Type II (TGFβR2) TGFβ Receptors to
augment signaling via the canonical signaling pathway that is
dependent on the phosphorylation and nuclear translocation of the
Smads (Derynck and Zhang, 2003). Deletion of the cytoplasmic domain
does not inhibit the ability of TGFβR3 to present ligand to TGFβR1 and
TGFβR2 and subsequently augment the canonical signaling pathway
(Blobe et al., 2001b). The results of targeting TGFβR3 inmice (Compton
et al., 2007) and cardiac cushion explants (Brown et al., 1999)
demonstrate a unique and non-redundant role for TGFβR3 in addition
to ligand presentation. Regulation of the migration and invasion of
several cancer cell lines has been shown to require the cytoplasmic
domain of TGFβR3 (Lee et al., 2009a; Mythreye and Blobe, 2009)
suggesting the presence of a noncanonical signaling pathway activated
by TGFβR3.
Efforts to understand this noncanonical pathway downstream of
TGFβR3 have focused on the identiﬁcation of proteins that interact
with the cytoplasmic domain of the receptor. Phosphorylation of
Thr841 by TGFβR2 has been shown to be required for βarrestin2
binding and leads to TGFβR3 internalization and down-regulation of
TGFβ signaling (Chen et al., 2003). The 3 C-terminal amino acids of
TGFβR3, STA, serve as a Class I PDZ binding motif and bind the
scaffolding protein, GIPC (GAIP-interacting protein, C terminus)
(Blobe et al., 2001a). Interaction with GIPC stabilizes TGFβR3 at the
surface and enhances TGFβ signaling (Blobe et al., 2001a). The
interaction between TGFβR3 and either βarrestin2 (You et al., 2009)
or GIPC (Lee et al., 2009a; Mythreye and Blobe, 2009) have been
reported to regulate cell behavior, speciﬁcally proliferation, invasion
and cell migration in breast and ovarian cancer cell lines.
Here we demonstrate that the loss of TGFβR3 results in decreased
proliferation and invasion in intact embryos and cultured epicardial
cells. The decreased invasion of epicardial cells in vitro is seen in
response to not only TGFβ1 and TGFβ2 but also FGF2 and HMW-HA
suggesting a dysregulation of key regulators of epicardial cell behavior
following the loss of TGFβR3. The restoration of the invasive response
to all these ligands in Tgfbr3−/− cells was shown to be dependent on
the cytoplasmic domain of TGFβR3, speciﬁcally the 3 terminal amino
acids, and interaction with GIPC. Based on our observations we
propose that failed coronary vessel development in Tgfbr3−/−mice is
at least partly due to decreased epicardial cell proliferation and
mesenchymal cell invasion which provides fewer cells to participate
in coronary vessel development.
Materials and methods
Generation of embryos
Tgfbr3+/− mice were generated as described (Compton et al.,
2007) and maintained on a C57BL/6 SV129 mixed background.
Tgfbr3+/− littermates were crossed to generate Tgfbr3+/+ and
Tgfbr3−/− embryos.
Cell culture
Immortalized epicardial cell lines were obtained as previously
described (Austin et al., 2008). To maintain the immortalized state,
cells were grown in immorto media: DMEM containing 10% FBS (fetal
bovine serum), 100 U/ml Penicillin/Streptomycin (P/S), 1× Insulin–
Transferrin–Selenium (ITS; 1 μg/ml insulin, 5.5×10−4 μg/ml transferrin,
0.677 μg/ml selenium), and 10 U/ml (interferon γ) INFγ at 33 °C. For
experiments, the T antigen was silenced by culturing at 37 °C in theabsence of ITS or I INFγ. Multiple Tgfbr3+/+ and Tgfbr3−/− littermate
pairs were used where available. E11.5 epicardial cells were used in all
experiments unless otherwise speciﬁed.
Growth factors
TGFβ1, TGFβ2, andhighmolecularweighthyaluronic acid (HMW-HA)
(~980 kDa) were purchased from R&D Systems. FGF-2, PDGF-AA, PDGF-
BB, EGF, and VEGF were purchased from (Pepprotech).
Immunohistochemistry
Tgfbr3+/+ and Tgfbr3−/− cells were plated at a density of 25,000
cells per well in one well of a 4-well collagen coated chamber slide
and allowed to adhere overnight at 37 °C. The following day themedia
was replaced with DMEM containing 5% FBS and incubated with
vehicle (4 mM HCl/0.01% BSA), 250 pM TGFβ1 or TGFβ2. After a
72 hour incubation period at 37 °C, cells were ﬁxed. For ZO-1 staining,
cells were ﬁxed in 70% methanol on ice for 10 min; for SM22α, 2%
paraformaldehyde (PFA) for 30 min and permeabilized with PBS and
0.2% Triton X-100 for 5 min at room temperature. Cells immuno-
stained for ZO-1were blockedwith 2% bovine serum albumin (BSA) in
PBS for 1 h and incubated with dilute primary antibody (ZO-1,
2 μg/ml, Zymed) overnight at 4 °C. For SM22α (Abcam) cells were
blocked with 5% horse serum, and incubated with primary antibody
(SM22α, 1:200) overnight at 4 °C. Primary antibody detection was
with goat anti-rabbit cy3 (ZO-1) or donkey anti-goat cy3 (SM22α)
secondary antibody (1:800; Jackson ImmunoResearch). Cells infected
with adenovirus co-expressing GFP and TGFβR3 were ﬁxed in 2%PFA
and stained for TGFβR3 (5 μg/ml, AF-242-PB, R&D) for 1 h at RT, and
detected with Alexa555 conjugated donkey anti-goat antibody
(Invitrogen) for 1 h at RT. Nuclei were stained with 4′,6-diamidino-
2-phenylinodole (DAPI; Sigma). Photomicrographs were captured
with Nikon Eclipse TE2000-E microscope and QED imagining
software.
qRT-PCR
Tgfbr3+/+ and Tgfbr3−/− cells were seeded at 200,000 cells per well
of a 6well tissue culture plate and allowed to adhere overnight at 37 °C.
The following day the media was replaced with DMEM containing 5%
FBS and incubated with vehicle, 250 pM TGFβ1 or TGFβ2. After a
72 hour incubation period at 37 °C, total RNA was isolated using the
TRIzol reagent (Invitrogen) according to the manufacturer's protocol.
cDNA was generated from 1 μg total RNA using oligo-dT primers and
Superscript III polymerase (Invitrogen). Real-time PCR analysis was
donewith iQ SYBR Green Supermix (Bio-Rad) in the Bio-Rad iCycler for
40 cycles. The expression levels are calculated using the ΔΔCT method.
The threshold cycle (CT) represents the PCR cycle at which an increase
of the reporter ﬂuorescence above the baseline is ﬁrst detected.
The fold change in expression levels, R, is calculated as follows:
R=2−ΔΔCT (where R=2(ΔCT treated−ΔCT control)). This method normalizes
the abundance of all transcripts to the constitutive expression level of
GAPDH RNA. Primer pairs for the smoothmusclemarkers, Sm22α, SMαA,
and calponin are as follows:Gene Sense primer (5′→3′) Anti-sense primer (5′→3′)Sm-22α AGCCAGTGAAGGTGCCTGAGAAC TGCCCAAAGCCATTAGAGTCCTC
SmαA GAGAAGCCCAGCCAGTCG CTCTTGCTCTGGGCTTCA
Calponin GAAGGCAGGAACATCATTGGACTG CTCAAAGATCTGCCGCTTGGTGCC
GAPDH ATGACAATGAATACGGCTACAG TCTCTTGCTCAGTGTCCTTGWound healing assay
Cells were seeded in a 35-mm culture plate coatedwith collagen at a
density of 3×106 cells/plate in immorto media and incubated at 33 °C.
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reaching conﬂuency, cellswere starvedwithDMEMcontaining0.5% FBS
and 100 U/ml P/S and incubated overnight at 37 °C. Eight 1-mmcircular
cell free areas were created with a stabilized rotating silicone tip, and
immediately photographed.Wound closure wasmonitored by for 72 h.
The denuded areawasmeasured using ImageJ software. Percentwound
closure relative to the initial wound area was calculated. Experiments
were repeated three times.
Time lapse, two dimensional motility assay
Cells were seeded in 35 mm culture plates, either coated with
collagen or containing 1 ml collagen gel, prepared at a density of
1.75 mg/ml as described (Runyan and Markwald, 1983). Two or four
sister cultures, containing cells derived from littermate embryos, were
recorded with an automated inverted microscope system (Leica
DMIRE2, Leica Microsystems, Germany) equipped with a stage-
attached incubator (Perryn et al., 2008). Images (608×512 pixels
spatial and 12 bit intensity resolution) were obtained with a 10×
objective (0.30 N.A.) and a cooled Retiga 1300 camera (QImaging,
Burnaby, British Columbia). The control software recorded multiple
microscopic ﬁelds within each culture dish. The time lag between
consecutive image frames was 10 min.
Cell movements were obtained from the recorded image
sequences by two independent procedures. Manual cell tracking
(Perryn et al., 2008) results in cell trajectories over long time periods,
but the number of cells tracked is limited to 20–30 per ﬁeld, around
10% of the cells present. An automated ﬂow ﬁeld estimator (Particle
Image Velocimetry (PIV) algorithm (Zamir et al., 2005), combined
with a cell/background segmenter (Wu et al., 1995) yields unbiased
velocity ﬁelds over the entire cell covered area, without distinguishing
individual cells.
Cell displacements can be characterized by the meanmagnitudes of
displacements during various time intervals as d(τ)={|xi(t+τ)−
xi(t)|}i,twhere xi(t) denotes the position of cell i at various time points t,
and the average {}i,t is calculated for all possible choices of i and t (Rupp
et al., 2008). Speed values are deﬁned as d(τ=1 h), i.e., mean cell
displacements during a 1 hour long time period (6 frames). The PIV
method directly yields speed values (albeit not for each cell but rather
per unit area) when the compared images were recorded 1 h apart.
For statistical purposes, we comparedmean speed values obtained
from independent time lapse recordings (n≥3).
Proliferation
BrdU incorporation in vitro
Cells were plated in 4-well collagen coated chamber slides at a
density of 25,000 cells/well and were allowed to attach overnight at
37 °C in DMEM containing 10% FBS and 100 U/ml Penn/Strep. To
synchronize at G0, 24 h post-plating, cells were serum starved in
DMEM containing 0.5% FBS and 100 U/ml Penn/Strep overnight,
followed by replacement of DMEM containing 10% FBS and 100 U/ml
P/S. Cells were ﬁxed in ethanol at 24, 48 and 72 h after replacing
growth medium. BrdU (bromodeoxyuridine) incorporation assay was
carried out as instructed by manufacturer (Roche: BRDU Labeling and
Detection Kit II). Random ﬁelds were selected and photographed for
each well using Nikon Eclipse TE2000-E microscope and QED imaging
software. Percent proliferation was calculated by counting the
number of BrdU positive cells in a total of 500 cells per genotype at
each time point. Experiments were repeated three times on cells from
one littermate pair.
MTS assay
This method relies on the in vivo reduction of MTS tetrazolium to a
colored formazan product by NADPH in metabolically active cells. The
product formed is read at 490 nm and is directly proportional to thenumber of living cells in culture. Cells were plated in triplicate in a 96-
well plate at a density of 5000 cells/well in 100 μl of DMEM containing
10% FBS and 100 U/ml P/S overnight at 37 °C. At 24, 48, and 72 h post-
plating, 20 μl of substrate (Promega: Cell Titer 96 Aqueous Solution)
was added to each well. Colorimetric reaction was allowed to proceed
for 30 min at 37 °C, followed by reading at 490 nm. Experiments were
repeated three times in triplicate per littermate pair. At least 3
different littermate pairs were analyzed.
BrdU incorporation in vivo
Pregnant mice at E12.5 and E13.5 were injected with BrdU
100 μg/kg at 6 h, 4 h, and 2 h before sacriﬁce. The embryos were
genotyped and embedded and Tgfbr3+/+ and Tgfbr3−/− littermate
embryos were sectioned. Sections (7 μm) through the heart were
blocked with 5% Normal Donkey Serum/1% BSA and immunostained
with a rat Anti-BrdU antibody (Accurate Chemical & Scientiﬁc Corp;
1:200) and an AlexaFluor 594 Donkey Anti-Rat secondary antibody
(Invitrogen, 1:200). DAPI was used to stain nuclei. Photographs of each
section were acquired using Nikon Eclipse TE2000-Emicroscope at 20×
magniﬁcation and QED imaging software. The total number of nuclei
and the number of BrdU positive nuclei were determined in
representative sections of the epicardium using Image J software. The
percentage of BrdU positive nuclei were calculated as a measure of cell
proliferation. Three animals per genotype, per stage were analyzed.
Apoptosis assays
Caspase 3/7 homogenous assay
Cells were plated in triplicate in a 96-well plate at a density of
10,000 cells/well in 100 μl of DMEM containing 10% FBS and 100 U/ml
P/S overnight at 37 °C. At each time point, 24, 48, and 72 h post-
plating, 100 μl of substrate (ApoONE Homogenous Caspase 3/7 Assay;
Promega) was added to each well. Colorimetric reaction was allowed
to proceed for 2 h at room temperature. Caspase 3/7 activity was then
detected by reading the ﬂuorescence of each well (Ex: 499 nm, Em:
521 nm). Experiments were repeated three times in triplicate per
littermate pair. At least 3 different littermate pairs were analyzed.
Trypan blue exclusion
Cells were plated in duplicate in 12-well collagen coated plates a
density of 100,000 cells/well and were allowed to attach overnight at
37 °C in DMEM containing 10% FBS and 100 U/ml Penn/Strep. At 24,
48 and 72 h post-plating, cell were trypsinized and re-suspended in
500 μl media. Trypan bluewas added to cells at a 1:1 ratio and allowed
to sit at room temperature for 1 min. Five hundred cells per genotype
were counted at each time point, and the proportion of trypan blue
positive cells to total cells was calculated Experiments were repeated
three times in triplicate per littermate pair.
TUNEL in vivo
E12.5 and E13.5 embryos were genotyped, embedded, and
Tgfbr3+/+ and Tgfbr3−/− littermate embryos were sectioned. TUNEL
staining was performed using DeadEnd Fluoremetric TUNEL System
(Promega) on 7 μm sections through the heart and the nuclei stained
with DAPI. Photographs of each section were acquired using Nikon
Eclipse TE2000-E microscope and QED imaging software. The total
number of nuclei and the number of TUNEL positive nuclei were
determined in representative sections of the epicardium to determine
the percentage of apoptotic cells present. Three animals per genotype,
per stage were analyzed.
Invasion assays
Calcein labeled/plate reader
To determine the invasive potential of immortalized epicardial
cells in response to growth factor stimulation, a modiﬁed Boyden
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described (Craig et al., 2010b). Brieﬂy, cells were ﬂuorescently labeled
with CalceinAM (BD Biosciences) and then plated at 12,000 cells per
well in DMEM containing 0.5% FBS (fetal bovine serum) in the top
chamber. Cells were then allowed to settle overnight at 37 °C. The
following day, DMEM containing 20% FBS±vehicle (4 mM HCl/0.1%
BSA), 250 pM TGFβ1 or TGFβ2 (R&D Systems) or 10 ng/ml FGF-2,
PDGF-AA, PDGF-BB, EGF, or VEGF was added to the bottom chamber
and incubated for an additional 24 h at 37 °C. Cells receiving HMW-HA
treatment were pre-treated with 300 μg/ml HMW-HA (unless
otherwise speciﬁed) in DMEM containing 0.5% FBS in the top well
for 30 min. Media was then removed and replaced with fresh DMEM
containing 0.5% FBS. 300 μg/ml HMW-HA was then added to the
bottom chamber as described for the other ligands. The top insert was
then removed and placed in a plate containing 0.25% Tryp-
sin/2.21 mM-EDTA in HBSS (CellGro). Cells were allowed to detach
from the membrane into the trypsin containing plate, which was then
read using SpectraMax 96-well plate reader (Ex: 485, Em: 538, Cutoff:
530; sensitivity: 30). Relative invasion was calculated by normalizing
treatment to vehicle treated groups.
Crystal violet stain
Cells were plated as described above. Instead of placing wells in
trypsin, membranes were ﬁxed in 2.5% Gluteraldehyde (Sigma) for
2 min, rinsed once with 1× PBS then stained in 0.4% Crystal violet
(Fisher) for 5 min, and mounted. Photographs of each membrane
were acquired using Nikon Eclipse TE2000-E microscope and QED
imaging software.
WT-1 staining in vivo
E13.5 embryos were genotyped, embedded, and Tgfbr3+/+ and
Tgfbr3−/− littermate embryos were sectioned. Sections through the
heart were immunostained with a rabbit anti-WT-1 (Santa Cruz,
1:200) and the nuclei stained with DAPI. Photographs of each section
were acquired using Nikon Eclipse TE2000-E microscope at 40×
magniﬁcation and QED imaging software. The total numbers of WT-1
positive cells were determined in representative sections of the heart
to determine the percentage of WT-1 positive cells invading the
subepicardial space and myocardium.
Expression analysis
Expression levels of LYVE1, CD44, FGFR1, FGFR2b, FGFR2c, FGFR3
and FGFR4 were analyzed using qRT-PCR as described above. Primer
sequences were previously published and purchased from IDT (Craig
et al., 2010b; Quarto and Longaker, 2008).Gene Sense primer (5′→3′) Anti-sense primer (5′→3′)Lyve1 CAGCATTCAAGAACGAAGCAG GCCTTCACATACCTTTTCACG
CD44 TCCTTCTTTATCCGGAGCAC AGCTGCTGCTTCTGCTGTACT
Fgfr1 GTGGCCGTGAAGATGTTGAAGTCC GCCGGCCGTTGGTGGTTTT
Fgfr2b CACCCGGGGATAAATAGCTCCAATG GCTGTTTGGGCAGGACAGT
Fgfr2c CACCCCGGTGTTAACACCACGG CTGGCAGAACTGTCAACCATG
Fgfr3 TGCCGGCCAACCAGACAGC GCGCAGGCGGCAGAGTATCAC
Fgfr 4 ATGAGCCGGGGAGCAGCAATGTT GGGGGATGGCAGGGGGTGGTGWestern blots
Tgfbr3+/+ and Tgfbr3−/− littermate epicardial cells were lysed and
diluted in TNEN buffer (1 M Tris base, 5 M NaCl, 0.5 M EDTA and
NP40) as described (Craig et al., 2010b). Total cellular lysates were
then resolved by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and transferred onto a polyvinylidene diﬂuoride
(PVDF)membrane. After blocking in 3% BSA, membranes were probed
with Rat anti-CD44 antibody (clone KM201) (Southern Biotech),
rabbit anti-LYVE1 (XLKD1) Antibody (C-term) (Abgen). β-actin(Afﬁnity Bio Reagents) was used as a loading control. TGFβR3
expression was conﬁrmed using goat-polyclonal antibody (AF-242-
PB) (R&D) and donkey anti-goat-HRP secondary R&D). Detection was
performed using Super Signal West Pico substrate (Pierce).
Adenovirus infections
Adenoviruses were generated using the pAdEasy system (He et al.,
1998). All concentrated viruses were tittered by performing serial
dilutions of the concentrated virus and counting the number of GFP-
expressing 293 cells after 18–24 h. The following adenoviruses co-
expressing GFP were used: full length TGFβR3 (FL), TGFβR3 missing
the cytoplasmic domain (CYTO) or the last 3 amino acids (Δ3), or
GIPC. Cells were plated in collagen coated 6 well dishes at a density of
200,000 cells per well in immorto media overnight at 33 °C. The
following day, virus was added directly to the cells at a ﬁnal
concentration of 108 PFU/ml and allowed to incubate for an additional
24 h. The next day cells were plated for invasion or proliferation
assays as described above.
Transfections
siRNA
Cells were plated at a density of 200,000 per well of 6-well plate.
The following day cells were transfected with 2 μg siRNA (Ambion) and
8 μl Xtreme siRNA Transfection Reagent (Roche). Sequences for siRNA
used are as follows: GIPC1: sense 5′-GCAGUGUGAUUGACCACAUtt-3′,
anti-sense 5′-AUGUGGUCAAUCACACUGCct-3′. At 48 h post-transfection
cells were harvested for qRT-PCR to conﬁrm knockdown of Gipc1(sense,
5′-TGGTTCAGGCCCACAA-3′; anti-sense, 5′-TCTCTAGCAAGTCATCCACC-
3′), or used directly for invasion assays. Where overexpression of
TGFβR3 was done in conjunction with knockdown of GIPC1, cells were
transfected with siRNA, then infected with adenovirus 24 h after, and
plated for invasion assays 24 h after that.
Plasmids
Cells were plated at a density of 50,000 per well of 6-well plate.
The following day cells were transfected with 2 μg pcDNA3.1 vector
alone or expressing full length TGFβR3-F), TGFβR3-CYTO or
TGFβR3-Δ3 and 8 μl FugeneHD Transfection Reagent (Roche). After
48 h, cells were harvested for Western blot analysis.
Statistical analysis
Paired student t-test was used to establish signiﬁcance. Data are
presented as the average of three experiments±SEM for one
littermate pair, unless otherwise speciﬁed. P-values of b0.05 were
considered signiﬁcant.
Results
Epicardial cells in Tgfbr3−/− embryos display decreased proliferation
and invasion
Deletion of Tgfbr3 in themouse results in death at E14.5 due to failed
coronary vessel development that is characterized by an abnormal
epicardium, increased subepicardial space, and poorly developed,
dysmorphic vessels (Compton et al., 2007). These observations suggest
that although the epicardium is formed in Tgfbr3−/− embryos, aberrant
epicardial cell behavior may underlie the failure of coronary vessel
development. Therefore we chose to measure epicardial cell prolifer-
ation, apoptosis, and invasion in vivo as an initial attempt to determine
themechanisms responsible for failed coronary vessel development. To
determine the rate of epicardial cell proliferation, pregnant Tgfbr3+/−
mice were injected with BrdU and embryos harvested at E12.5 and
E13.5, a time when the epicardium covers the heart and epicardial cell
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(Fig. 1A). Epicardial cells were counted and the percent of BrdU positive
cells determined. No difference was noted at E12.5, however at E13.5
epicardial cells in Tgfbr3+/+ embryos showed signiﬁcantly more
proliferation than Tgfbr3−/− littermates (25.3%±0.88% vs
15.7%±1.58%, p=0.012; n=3) (Fig. 1B). Apoptosis was assessed in
E12.5 and E13.5 littermate embryos by TUNEL analysis.We noted a very
low rate of apoptosis in Tgfbr3+/+ embryos (b4%) and no signiﬁcant
difference between genotypes (Supplementary Fig. 1A). After the
epicardium covers the surface of the heart in vivo, a subset of epicardial
cells undergo EMT and invade the subepicardial space with some cells
continuing into the myocardium (Olivey et al., 2004). We assessed
epicardial cell invasion in E13.5 embryos by detecting the epicardial cell
marker WT1 (Moore et al., 1999). Tgfbr3−/− embryos display a
signiﬁcantly lower number of WT-1 positive cells that invade the
subepicardial space or the myocardium (20.4%±3.71) compared to
Tgfbr3+/+ littermates (31.0%±2.87) (Figs. 1C and D; Supplementary
Figs. 2A and B). These data suggest that both decreased cell proliferation
and decreased cell invasion contribute to failed coronary vessel
development in Tgfbr3−/−mice.Fig. 1. Epicardial cells in Tgfbr3−/− embryos show decreased proliferation and invasion in v
BrdU positive cells are indicated by solid arrowheads. White dashed line demarcates myoc
number of BrdU positive cells per total number of DAPI stained nuclei (n=3 embryos
Representative WT1 positive mesenchymal cells are identiﬁed by the open circles. Repres
derived mesenchymal cells in the subepicardial space are identiﬁed by the open arrowhead
mesenchymal cells per total WT1 positive cells (n=3 embryos per genotype (*pb0.05)). (Tgfbr3−/− epicardial cells display decreased proliferation and invasion
in vitro
Given the alterations in epicardial cell proliferation and invasion
noted in Tgfbr3−/− embryos, we developed immortalized epicardial
cell lines from Tgfbr3+/+ and Tgfbr3−/− embryos that would allow us
to probe TGFβR3 regulation of epicardial cell behavior in vitro. Since
we have previously immortalized epicardial cells from Tgfbr3+/+
embryos and shown that these cells behave similarly to freshly
isolated primary cells (Austin et al., 2008), we used this same
approach to generate and characterize epicardial cells from Tgfbr3+/+
and Tgfbr3−/− littermate pair embryos. We ﬁrst measured the
proliferation rates of Tgfbr3+/+ and Tgfbr3−/− epicardial cells. As
measured by BrdU incorporation, Tgfbr3+/+ cells exhibit proliferation
rates that peak at 48 h and decline to basal levels by 72 h. Tgfbr3−/−
cells show a signiﬁcantly reduced rate of proliferation that is
sustained throughout the time course examined (Figs. 2A and B).
We used an MTS assay as a second independent approach to conﬁrm
this initial observation. Tgfbr3−/− cells had a cell density 50% lower at
48 h and 62% lower at 72 h, indicating an overall lower rate ofivo. (A) Heart sections from E12.5 and E13.5 embryos stained for BrdU. Representative
ardium from the epicardium and subepicardial space. (B) Percent proliferation is the
per genotype, per stage (*pb0.05)). (C) Sections stained for WT1 in E13.5 hearts.
entative cells in the epicardium are indicated by solid arrowheads, while epicardially
s. (D) Percent invasion into myocardium is calculated as the number of WT1 positive
a = atria, v = ventricle).
Fig. 2. Cultured Tgfbr3−/− epicardial cells show decreased proliferation and invasion. (A) Photomicrographs of cells incubated with BrdU and ﬁxed at 24, 48 and 72 h after initial
seeding on 4-well collagen coated slides. (B) Quantitation of percent BrdU incorporation (n=3, *p=0.001) (C) Measurement of cell number by MTS assay (experiments were
repeated 3 times in triplicate, results for one littermate pair shown, *pb0.05). (D) Quantitation of invasion using a modiﬁed Boyden chamber assay of one littermate pair
(experiments were repeated 3 times in replicates of 6, *=pb0.05). (E) Graph quantifying percent wound closure over 72 h after conﬂuent cell monolayers were wounded using a
rotating silicon tip (experiments were repeated three times, results for one littermate pair shown, *pb0.05). (F) Mean cell displacements values using live video microscopy of one
littermate pair. The difference between genotypes is not signiﬁcant.
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We measured apoptosis in vitro through Caspase 3/7 activity and
trypan blue exclusion (Supplementary Figs. 1B and C). Tgfbr3−/− cells
have an elevated level of apoptosis at all-time points as measured by
both methods. This increase in apoptosis was not seen in vivo. This
may be partially explained by the inherent low levels of apoptosis that
would make detecting small changes in apoptosis difﬁcult. Alterna-
tively, in vitro cells may respond to the stress inherent in culture by
increasing apoptosis while cells in vivo, absent this stress, may have
unaltered rates of apoptosis. To examine epicardial cell invasion we
used amodiﬁed Boyden Chamber assay as a model system. Incubation
of Tgfbr3+/+ cells with either 250 pM TGFβ1 or TGFβ2 induces a 7 and
6 fold increase in cell invasion over vehicle, respectively. In contrast,
epicardial cells from Tgfbr3−/− littermates incubated with either
TGFβ1 or TGFβ2 induced only a 2-fold increase in invasion (Fig. 2D,
Supplementary Fig. 3). The decreased proliferation and invasion seen
in Tgfbr3−/− epicardial cells in vitro support the use of these cells as a
model system to elucidate the mechanisms by which the loss of
TGFβR3 alters proliferation and invasion in vivo.
Since Tgfbr3−/− epicardial cells show decreased invasion in vitro
and in vivo, we asked whether Tgfbr3−/− cells displayed impaired
motility in a 2 dimensional assay that does not require matrix
invasion. We used an in vitro wound healing assay to initially probe
epicardial cell motility. Tgfbr3+/+ cells close a wound by 48 h.
However cells from Tgfbr3−/− littermates require an additional 24 h
(Fig. 2E and Supplementary Fig. 4A). Since wound closure may be
affected by both cell motility and cell proliferation, we used time lapse
video microscopy to determine the role of motility directly in the
delay of wound healing. Four littermate cell line pairs were compared,
and for each pair multiple independent time lapse recordings were
used to compute average motility. In these 2-dimensional motilityassays, Tgfbr3−/− cells from one littermate pair display a slightly
faster motility rate (13%; pb0.001) (Supplementary Fig. 4B). The
motility of Tgfbr3+/+ and Tgfbr3−/− cells substantially increases on
hard substrates: cells move on collagen coated glass threefold faster
than on the surface of a collagen gel (Fig. 2F). However, in each case
altered cell motility could not explain the delayed wound healing in
Tgfbr3−/− cells, thus decreased wound healing is likely due to
decreased rates of proliferation.
Tgfbr3−/− epicardial cells can undergo EMT and smooth muscle
differentiation in response to TGFβ1 or TGFβ2
Epicardial cells give rise to the vascular smooth muscle cells that
are required for vessel stabilization and maintenance (Mikawa and
Gourdie, 1996). Analysis of Tgfbr3−/− embryos suggest that epicardial
cells do give rise to smooth muscle cells in vivo (Compton et al., 2007)
but, given the importance of this cell type in the stabilization and
maintenance of the coronary vessels, we chose to directly test for any
requirement of TGFβR3 in epicardial cell differentiation into smooth
muscle. We have previously shown that TGFβ1 or TGFβ2 induces loss
of epithelial character and smoothmuscle differentiation in Tgfbr3+/+
epicardial cells (Austin et al., 2008). Here, immunostaining revealed
that both Tgfbr3+/+ and Tgfbr3−/− cells have abundant expression of
the tight junction protein zonula occludens-1 (ZO-1) at the cell
borders (Fig. 3A). This pattern of ZO-1 expression is characteristic of
epithelial cells (Lee et al., 2009b). In both Tgfbr3+/+ and Tgfbr3−/−
cells, 250 pM TGFβ1 or TGFβ2 caused the loss of cell border
localization of ZO-1 indicative of the loss of epithelial character.
These data are consistent with the analysis of Tgfbr3−/− embryos
which show that epicardial cells can undergo EMT evident by the
appearance of epicardially derived cells in the subepicardial space.
Fig. 3. Cultured Tgfbr3−/− epicardial cells can undergo EMT and smooth muscle differentiation. Tgfbr3+/+ and Tgfbr3−/− cells were incubated with vehicle, 250 pM TGFβ1 or TGFβ2
for 72 h. (A) Immunohistochemistry: Tgfbr3+/+ (top) and Tgfbr3−/− (bottom) cells incubated with vehicle localize the epithelial marker, ZO-1 to cell margins. TGFβ1 or TGFβ2
induces loss of cell–cell contact and loss of ZO-1 from cell margins. (B) Tgfbr3+/+ (top) and Tgfbr3−/− (bottom) cells incubated with vehicle do not show SM22α in stress ﬁbers.
TGFβ1 or TGFβ2 induces SM22α expression in stress ﬁbers in both genotypes. (C and D) Induction of the smooth muscle markers, SM22α, SMαA, and Calponin was evaluated using
qRT-PCR analysis (n=3; *pb0.05).
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smooth muscle marker SM22α in stress ﬁbers (Fig. 3B). Smooth
muscle marker expression was conﬁrmed by qRT-PCR, and both
TGFβ1 and TGFβ2 signiﬁcantly induced the expression of SM22α,
SMα-actin (SMαA), and calponin in Tgfbr3−/− cells (Figs. 3C and D).Together, these data demonstrate that Tgfbr3 is not required for the
loss of epithelial character or smooth muscle differentiation in
epicardial cells and supports the conclusion that loss of the ability of
epicardial cells to differentiate into smoothmuscle is not a component
of the phenotype of the Tgfbr3−/− mouse.
338 N.S. Sánchez et al. / Developmental Biology 358 (2011) 331–343Loss of TGFβR3 results in decreased responsiveness to not only TGFβ1
and TGFβ2 but to other key regulators of cell invasion
Since the loss of Tgfbr3 results in decreased cell invasion due to
decreased TGFβ responsiveness, and several other growth factors
have been shown to mediate epicardial EMT and invasion (Craig et al.,
2010b; Mellgren et al., 2008; Morabito et al., 2001; Tomanek et al.,
2001, 2002), we next asked if loss of Tgfbr3 altered responsiveness to
other key regulators of cell invasion. High molecular weight
hyaluronic acid (HMW-HA), a major component of the ECM in the
developing heart (Camenisch et al., 2000), has recently been
implicated in mediating epicardial EMT and invasion (Craig et al.,
2010b). Furthermore, TGFβ2 has been reported to regulate HAS-2
expression, the gene responsible for hyaluronic acid synthesis (Craig
et al., 2010a). Given the decreased responsiveness to TGFβ2-induced
invasion observed in Tgfbr3−/− cells in vitro and the role of HMW-HA
in regulating epicardial cell behavior, we assessed the ability of
Tgfbr3+/+ and Tgfbr3−/− cells to invade collagen gels in response to
HMW-HA. Tgfbr3+/+ and Tgfbr3−/− cells were incubated with 0, 50,
75, 150 or 300 μg/ml HMW-HA, and cellular invasion analyzed.
Tgfbr3+/+ cells show a concentration dependent increase in invasion
with HMW-HA, however, Tgfbr3−/− cells do not (Fig. 4A). To
determine whether the loss of responsiveness to HMW-HA correlated
with loss of HA receptor expression, we detected levels of the HA
receptors, LYVE1 and CD44, using qRT-PCR andWestern blot analysis.
Protein and mRNA levels of both receptors are not signiﬁcantly
different between genotypes; hence decreased responsiveness to
HMW-HA does not correlate with loss of HA receptor expression
(Fig. 4B). Additional factors that mediate epicardial EMT and invasion
include FGF2, PDGFAA, PDGFBB, EGF, and VEGF (Mellgren et al., 2008;
Morabito et al., 2001; Tomanek et al., 2001, 2002). Therefore, to
determine whether there is a global defect in the ability of Tgfbr3−/−
cells to execute invasive cell motility, we assessed whether respon-Fig. 4. Loss of Tgfbr3 results in decreased response to HMW-HA and FGF-2. Invasionwas analy
Tgfbr3−/− littermate pair with HMW-HA. (B) Expression analysis using qRT-PCR (top) and
littermate pair. (C) Incubation with vehicle, 250 pM TGFβ2, or 10 ng/ml of FGF2, PDGFAA, P
littermate pair shown,*=pb0.05). (D) Expression analysis using qRT-PCR comparing FGFRsiveness to any of these factors was altered in Tgfbr3−/− cells.
Response to PDGFAA, PDGFBB, EGF, and VEGF is unaltered between
genotypes, however Tgfbr3−/− littermates display a decreased ability
to invade in response to FGF2 (1.5-fold relative to vehicle), a potent
inducer of epicardial cell EMT and invasion in vitro (Morabito et al.,
2001), when compared to Tgfbr3+/+ controls (2.25-fold relative to
vehicle) (Fig. 4C). Analysis of receptor expression using qRT-PCR
revealed no difference in FGF receptor expression (Fig. 4D). Collec-
tively, these data suggests that Tgfbr3−/− cells are competent to
execute invasive cell motility and reveal that TGFβR3 plays a central
role in regulating responsiveness not only to members of the TGFβ
family but select mediators of epicardial cell function such as HMW-
HA and FGF2.
Non-canonical signaling through TGFβR3 interaction with GIPC is
required for invasion
The mechanisms by which TGFβR3 signals are largely unknown.
The cytoplasmic domain of TGFβR3 is not required to present ligand to
TGFβR1 and TGFβR2 to augment canonical signaling (Blobe et al.,
2001b). Targeting TGFβR3 in mice (Compton et al., 2007) and cardiac
cushion explants (Brown et al., 1999) suggests a unique and non-
redundant role for TGFβR3 in addition to ligand presentation. To
determine a potential role of the cytoplasmic domain of TGFβR3 in
regulating proliferation and invasion, we expressed TGFβR3 mutants
missing portions of the cytoplasmic domain (Fig. 5A). The cytoplasmic
domain of TGFβR3 lacks enzymatic activity but the 3 C-terminal
amino acids bind the scaffolding protein GIPC1 (Blobe et al., 2001a).
We overexpressed in Tgfbr3−/− cells either full length TGFβR3 (FL),
TGFβR3 lacking the entire cytoplasmic domain (CYTO) or TGFβR3
lacking only the 3 C-terminal amino acids (Δ3) (Supplementary Figs.
5A–D). Overexpression of TGFβR3 FL in Tgfbr3−/− cells rescued both
proliferation (Supplementary Fig. 6A) and TGFβ, HMW-HA, and FGF-2zed as described in Fig. 2D for panels A and C. (A) Concentration response Tgfbr3+/+ and
western blot (bottom) comparing LYVE1 and CD44 levels in Tgfbr3+/+ and Tgfbr3−/−
DGFBB, VEGF or EGF. (Experiments repeated 3 times in replicates of 6, results for one
levels in Tgfbr3+/+ and Tgfbr3−/− littermate pair.
Fig. 5. The cytoplasmic domain of TGFβR3 and GIPC are required for invasion. Invasion was analyzed as described in Fig. 2D for all panels. (A) TGFβR3 contains a 43 amino acid
cytoplasmic domain whose C-terminal 3 amino acids, STA, bind GIPC. (B) Tgfbr3−/− epicardial cells infected with adenovirus co-expressing GFP and either FL, CYTO or Δ3
receptor and incubated with vehicle, 250 pM TGFβ2, 10 ng/ml FGF-2 or 300 μg/ml HMW-HA. (C) Tgfbr3+/+ or Tgfbr3−/− cells infected with adenovirus co-expressing GFP and
GIPC1. (D) Tgfbr3+/+ cells transfectedwith siRNA to GIPC1 and incubatedwith vehicle, 250 pM TGFβ2, 10 ng/ml FGF-2 or 300 μg/ml HMW-HA. (n=3, replicates of 6,*=pb0.05).
(E) Tgfbr3−/− cells infected with adenovirus expressing GFP or FL receptor, transfected with siRNA to GIPC1, and incubated with vehicle, 250 pM TGFβ2, 10 ng/ml FGF-2, or
300 μg/ml HMW-HA. (n=3, replicates of 4). ⁎[GFP+scramble+ligand] vs. [FL+scramble+ligand]; #[FL+scramble+TGFβ2] vs. [FL+GIPCsiRNA+TGFβ2]; $[FL+scramble+
FGF2] vs. [FL+GIPCsiRNA+FGF2]; and&[FL+scramble+HMW-HA] vs. [FL+GIPCsiRNA+HMW-HA]; pb0.05.
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sing cells (Fig. 5B). In contrast, overexpression of either TGFβR3 CYTO
or Δ3 did not rescue proliferation (Supplementary Fig. 6A) or invasion
in Tgfbr3−/− cells (Fig. 5B). These data demonstrate that the
cytoplasmic domain, and speciﬁcally the 3 C-terminal amino acids,
are required for the regulation of TGFβR3-mediated proliferation and
invasion by epicardial cells.
The interaction between TGFβR3 and GIPC1, through the 3 C-
terminal amino acids, has been reported to regulate cellular invasion
in breast cancer cell lines (Lee et al., 2009a). Therefore, we assessed
the role of GIPC in proliferation and invasion by overexpressing GIPC
in Tgfbr3+/+ and Tgfbr3−/− cells. Three isoforms of GIPC exist and wefound GIPC1 is the predominant form in epicardial cells. Over-
expression of GIPC1 had no effect on proliferation rate irrespective of
genotype (Supplementary Fig. 6B). Overexpression of GIPC1 en-
hanced cellular invasion by Tgfbr3+/+ cells but did not rescue
deﬁcient invasive cell motility by Tgfbr3−/− epicardial cells
(Fig. 5C). Knockdown of GIPC1 with either one of two speciﬁc siRNA
constructs in Tgfbr3+/+ epicardial cells reduced TGFβ2, HMW-HA, and
FGF-2-induced invasion to levels comparable to those observed in
Tgfbr3−/− cells (Fig. 5D) while having no effect on cellular
proliferation rates (Supplementary Figs. 6C and D). To directly
establish that TGFβR3-mediated invasion in response to TGFβ2,
FGF-2, and HMW-HA requires GIPC, we overexpressed TGFβR3-FL in
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HMW-HAmediated invasion (Fig. 5E). The addition of GIPC1 siRNA to
cells overexpressing TGFβR3-FL signiﬁcantly inhibited the ability of
TGFβR3-FL to mediate TGFβ2, FGF-2 or HMW-HA-induced invasion.
These data support the requirement of GIPC for TGFβR3-mediated
invasion in response to TGFβ2, HMW-HA, and FGF-2.
Discussion
The loss of Tgfbr3 in mice results in failed coronary vessel
development (Compton et al., 2007) but the mechanisms by which
TGFβR3 signals and regulates this process are largely unknown. Here
we show that the loss of TGFβR3 is associated with decreased
proliferation and invasion in both epicardial cells and the epicardium
of intact embryos. Surprisingly, the decreased invasion of epicardial
cells is seen in response to FGF2 and HMW-HA, known regulators of
epicardial cell behavior and coronary vessel development (Craig et al.,
2010b; Pennisi and Mikawa, 2009) in addition to TGFβ1 and TGFβ2.
The responsiveness to these ligands in Tgfbr3−/− cells was found to be
dependent on the 3 terminal amino acids of the cytoplasmic domain
of TGFβR3 and interaction with GIPC indicating that TGFβR3 is
signaling via a mechanism distinct from ligand presentation and
activation of canonical TGFβ signaling. Based on our observations weFig. 6. Model of TGFβR3 regulation of epicardial cell behavior. (A) In Tgfbr3+/+ hearts (le
myocardium. Epicardial-derived cells (EPDCs) undergo EMT and invade the subepicardial
(yellow) and cardiac ﬁbroblasts (blue) while endothelial cells (purple) are contributed by t
and an impaired ability of these cells to invade results in fewer cells to participate in vessel d
TGFβ2 FGF2, and HMW-HA can be rescued by TGFβR3-FL which allows interaction with GIPC
rescue invasion. These data suggest that TGFβR3 and GIPC interaction are also required forpropose that failed coronary vessel development in Tgfbr3−/−mice is
due to decreased delivery of epicardially derived cells that are
required to participate in coronary vessel development. We suggest
that altered behavior in Tgfbr3−/− cells in vivo is at least partially due
to the loss of signaling from FGF2 and HMW-HA as well as TGFβ. Since
TGFβR3 signaling requires a speciﬁc cytoplasmic domain and the
interacting protein GIPC to support epicardial cell invasion and
responsiveness to TGFβ, FGF2, and HMW-HA, we propose that failed
interaction between TGFβR3 and GIPC in the Tgfbr3−/− embryo is
responsible for failed coronary vessel development (Fig. 6).
Our results showing that decreased proliferation and invasion are
associated with failed coronary vessel development suggest that the
time window during which cells must be delivered to the heart to
participate in coronary vessel development is relatively narrow. A
decrease in the number of cells available to participate in vessel
formation may be tolerated in other vascular beds, but the
dependence of embryo viability on coronary vessel formation by
E15.0 does not allow sufﬁcient time for the continued production and
delivery of lower numbers of cells to rescue coronary vessel
development. This is supported by several other gene knockouts
that affect coronary vessel development that have reported altered
proliferation, apoptosis, or invasion in the epicardium, epicardial-
derived cells, or myocardium (Lavine et al., 2006; Li et al., 2002;ft), the epicardium forms a continuous epicardial layer that is tightly opposed to the
space. Some of these cells invade the myocardium and become smooth muscle cells
he sinus venosus. In Tgfbr3−/− hearts (right), decreased proliferation of epicardial cells
evelopment. (B) In vitro, the invasion deﬁcit in Tgfbr3−/− cells seen in response TGFβ1,
. Expression of TGFβR3-Δ3 which lacks GIPC binding site, or targeting of GIPC, does not
regulating epicardial cell behavior in vivo.
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Understanding the pathways that regulate epicardial cell proliferation
and invasion during development has become increasingly important
as a mounting amount of evidence demonstrate that pathways that
regulate epicardial cell development are reinitiated during heart
regeneration. Injury models in zebraﬁsh uncovered a novel role for
the epicardium in the regeneration of myocardium accompanied by
the activation of developmental genes throughout the epicardium,
epicardial cell EMT, and the appearance of new vessels (Lepilina et al.,
2006). Mammals possess less regenerative capacity than zebraﬁsh but
analysis of the response of the epicardium to injury reveals striking
similarities (Bock-Marquette et al., 2009; Cai et al., 2008; Christoffels
et al., 2009; Rentschler and Epstein, 2011; Smart et al., 2007; Zhou et
al., 2008). For example in mice, a novel population of cells derived
from the epicardium have been found to increase after myocardial
infarction or aortic banding consistent with a role in injury response
(Russell et al., 2011). These data suggest that understanding the
factors that regulate epicardial cell proliferation and invasion may
provide the opportunity to target the epicardium to modulate the
response to injury in adults.
We had the surprising result that loss of TGFβR3 also altered
responsiveness to both HMW-HA and FGF2 despite unchanged levels of
their respective receptors. This resultwas speciﬁc toHMW-HAand FGF2
since epicardial cell invasion in response to PDGFAA, PDGFBB, VEGF, and
EGF is unaffected by the loss of TGFβR3. Both HMW-HA and FGF2 are
important regulators of epicardial cell invasion (Craig et al., 2010b;
Morabito et al., 2001). The loss of responsiveness of epicardial cells to
FGF2 and HMW-HA, in addition to TGFβ1 and TGFβ2, may explain how
the loss of a single gene, which disrupts several potential signaling
pathways, so dramatically alters themorphology of the epicardium and
myocardium in Tgfbr3−/− embryos. Altered myocardial morphology
and decreased myocardial proliferation is noted in a number of mouse
models where gene deletion alters the epicardium (Kwee et al., 1995;
Mahtab et al., 2008; Sridurongrit et al., 2008) and likely reﬂects thewell
documented requirement of intact epicardial–myocardial interaction
(Crispino et al., 2001; Kwee et al., 1995; Lavine et al., 2005; Merki et al.,
2005; Olivey and Svensson, 2010; Tevosian et al., 2000; Yang et al.,
1995) to support myocardial thickening (Weeke-Klimp et al., 2010;Wu
et al., 1999). Decreased myocardial proliferation has also been reported
in Tgfbr3−/− embryos (Stenvers et al., 2003). Our results suggest a
dysregulation of the ability of Tgfbr3−/− cells to respond to several
known regulators of epicardial and coronary vessel development (Craig
et al., 2010b; Pennisi and Mikawa, 2009) and establishes TGFβR3 as a
regulator of multiple signals that direct epicardial cell behavior.
Examinationof the ability to rescue thedeﬁcits seen in Tgfbr3−/− cells
by TGFβR3 mutants indicates a role for noncanonical TGFβ signaling in
the regulationof epicardial cell proliferation and invasion. Theexpression
of TGFβR3-CYTO or TGFβR3-Δ3 is unable to rescue demonstrating the
requirement of the cytoplasmic domain, and speciﬁcally the 3 C-terminal
amino acids, for signaling. Importantly, the cytoplasmic domain of
TGFβR3 is not required for ligand presentation and signaling via the
canonical TGFβpathway (Blobeet al., 2001a).Howcan the rescueof FGF2
and HMW-HA be explained? These ligands could bind TGFβR3 and
initiate signaling or these ligands could activate signaling through their
respective receptors that share a common downstreammediator that is
lost in Tgfbr3−/− cells. In support of directly signaling through TGFβR3, it
has been reported that FGF2 canbind to TGFβR3 (Andres et al., 1992) and
more recent data in valvular interstitial cells demonstrates a functional
link between FGF2 binding and TGFβR3 activation (Han and Gotlieb,
2011). In contrast, HMW-HA has not been reported to bind TGFβR3
consistent with the idea that TGFβ, FGF2, and HMW-HA may share a
common downstream mediator that is dysregulated in the absence of
TGFβR3.
The inability of TGFβR3-Δ3 to rescue identiﬁed a potential
mediator of this noncanonical pathway downstream of TGFβR3. The
scaffolding protein GIPC1 requires these same 3 C-terminal aminoacids to bind TGFβR3 (Blobe et al., 2001a). Interaction between
TGFβR3 and GIPC1 in cancer cell lines regulates cell migration and
invasion (Lee et al., 2009a), while the targeted deletion of GIPC1, or
synectin, in mice has been shown to attenuate the growth and
branching of coronary arterioles (Dedkov et al., 2007). In endothelial
cells, the interaction of GIPC1with syndecan-4, a co-receptor for FGF2,
(Tkachenko et al., 2006) or endoglin, a coreceptor for TGFβ, (Lee et al.,
2008) has been shown to regulate migration. Consistent with the
known role of the 3 C terminal amino acids of TGFβR3 in GIPC binding
(Blobe et al., 2001a), siRNA directed against GIPC1 decreased invasion
of Tgfbr3+/+ cells in response to TGFβ2, FGF2, or HMW-HA,
phenocopying loss of Tgfbr3. Further, siRNA directed against GIPC1
prevented rescue of invasion by TGFβR3-FL in Tgfbr3−/− cells. Taken
together, our data in epicardial cells are most consistent with the
interaction between the 3 C-terminal amino acids of the cytoplasmic
domain of TGFβR3 and GIPC being required for the regulation of
invasion. We conclude that TGFβR3 signaling via a noncanonical
signaling pathway that includes interaction with GIPC1 plays a key
role in epicardial cell function during coronary vessel development
and may provide a potential novel target for therapies directed at the
epicardium and epicardial derivatives.
In summary, Tgfbr3−/− mice have failed coronary vessel develop-
ment accompanied by hyperplasia of the subepicardial layer (Compton
et al., 2007) indicating that epicardial cells can undergo EMT and enter
the subepicardial matrix. Based on our observations we propose that
failed coronary vessel development in Tgfbr3−/−mice is at least partly
due to decreased epicardial cell proliferation and mesenchymal cell
invasion which limits the number of cells available to participate in
coronary vessel development (Fig. 6). We had the unexpected result
that Tgfbr3−/− epicardial cells have decreased responsiveness to FGF2
and HA in addition to TGFβ and we suggest that altered epicardial cell
behavior in Tgfbr3−/− cells is at least partially due to the loss of signaling
from these cues. Surprisingly,we found that TGFβR3 signaling requires a
speciﬁc cytoplasmic domain and the interacting protein GIPC to support
epicardial cells invasion and responsiveness to TGFβ, FGF2, and HMW-
HA. We propose that this failed interaction in the Tgfbr3−/− embryo is
responsible for failed coronary vessel development.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.08.008.
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